Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia

Abstract Antipsychotic effects seem to decrease in relapsed schizophrenia patients and the underlying mechanisms remain to be elucidated. Based on the essential role of polyunsaturated fatty acids in brain function and the treatment of schizophrenia, we hypothesize that disordered fatty acid metabol...

Full description

Bibliographic Details
Main Authors: Nana Li, Ping Yang, Mimi Tang, Yong Liu, Wenbin Guo, Bing Lang, Jianjian Wang, Haishan Wu, Hui Tang, Yan Yu, Xiangxin Wu, Cuirong Zeng, Ting Cao, Hualin Cai
Format: Article
Language:English
Published: Nature Portfolio 2022-02-01
Series:npj Schizophrenia
Online Access:https://doi.org/10.1038/s41537-022-00214-2
_version_ 1797428466868551680
author Nana Li
Ping Yang
Mimi Tang
Yong Liu
Wenbin Guo
Bing Lang
Jianjian Wang
Haishan Wu
Hui Tang
Yan Yu
Xiangxin Wu
Cuirong Zeng
Ting Cao
Hualin Cai
author_facet Nana Li
Ping Yang
Mimi Tang
Yong Liu
Wenbin Guo
Bing Lang
Jianjian Wang
Haishan Wu
Hui Tang
Yan Yu
Xiangxin Wu
Cuirong Zeng
Ting Cao
Hualin Cai
author_sort Nana Li
collection DOAJ
description Abstract Antipsychotic effects seem to decrease in relapsed schizophrenia patients and the underlying mechanisms remain to be elucidated. Based on the essential role of polyunsaturated fatty acids in brain function and the treatment of schizophrenia, we hypothesize that disordered fatty acid metabolism may contribute to treatment resistance in multi-episode patients. We analyzed the erythrocyte membrane fatty acids in 327 schizophrenia patients under various episodes (numbers of patients: first-episode drug naïve 89; 2–3 episodes 110; 4–6 episodes 80; over 6 episodes 48) and 159 age- and gender-matched healthy controls. Membrane fatty acid levels and PANSS scales were assessed at baseline of antipsychotic-free period and one-month of follow-up after treatment. Totally, both saturated and unsaturated fatty acids were reduced at baseline when compared to healthy controls. Subgroup analyses among different episodes indicated that in response to atypical antipsychotic treatment, the membrane fatty acids were only increased in patients within 3 episodes, and this therapeutic effects on omega-3 index were merely present in the first episode. Results of fatty acid ratios suggested that dysregulations of enzymes such as D6 desaturase, D5 desaturase, and elongases for polyunsaturated fatty acids in patients with multi-episode schizophrenia could account for the differences. Additionally, certain fatty acid level/ratio changes were positively correlated with symptom improvement. The alterations of C22:5n3 and omega-3 index, gender, and the number of episodes were significant risk factors correlated with treatment responsiveness. Using targeted metabolomic approach, we revealed the potential mechanisms underlying abnormal fatty acid metabolism responsible for reduced treatment response in patients with multi-episode schizophrenia.
first_indexed 2024-03-09T08:59:19Z
format Article
id doaj.art-75f5a6d2a56b413c994cf8c4b517ea6d
institution Directory Open Access Journal
issn 2334-265X
language English
last_indexed 2024-03-09T08:59:19Z
publishDate 2022-02-01
publisher Nature Portfolio
record_format Article
series npj Schizophrenia
spelling doaj.art-75f5a6d2a56b413c994cf8c4b517ea6d2023-12-02T12:09:07ZengNature Portfolionpj Schizophrenia2334-265X2022-02-018111210.1038/s41537-022-00214-2Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophreniaNana Li0Ping Yang1Mimi Tang2Yong Liu3Wenbin Guo4Bing Lang5Jianjian Wang6Haishan Wu7Hui Tang8Yan Yu9Xiangxin Wu10Cuirong Zeng11Ting Cao12Hualin Cai13Department of Pharmacy, the Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, the Second People’s Hospital of Hunan ProvinceDepartment of Pharmacy, Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, The Second Xiangya Hospital of Central South UniversityDepartment of Psychiatry, Changsha Psychiatric HospitalDepartment of Pharmacy, the Second Xiangya Hospital of Central South UniversityDepartment of Pharmacy, the Second Xiangya Hospital of Central South UniversityDepartment of Pharmacy, the Second Xiangya Hospital of Central South UniversityDepartment of Pharmacy, the Second Xiangya Hospital of Central South UniversityAbstract Antipsychotic effects seem to decrease in relapsed schizophrenia patients and the underlying mechanisms remain to be elucidated. Based on the essential role of polyunsaturated fatty acids in brain function and the treatment of schizophrenia, we hypothesize that disordered fatty acid metabolism may contribute to treatment resistance in multi-episode patients. We analyzed the erythrocyte membrane fatty acids in 327 schizophrenia patients under various episodes (numbers of patients: first-episode drug naïve 89; 2–3 episodes 110; 4–6 episodes 80; over 6 episodes 48) and 159 age- and gender-matched healthy controls. Membrane fatty acid levels and PANSS scales were assessed at baseline of antipsychotic-free period and one-month of follow-up after treatment. Totally, both saturated and unsaturated fatty acids were reduced at baseline when compared to healthy controls. Subgroup analyses among different episodes indicated that in response to atypical antipsychotic treatment, the membrane fatty acids were only increased in patients within 3 episodes, and this therapeutic effects on omega-3 index were merely present in the first episode. Results of fatty acid ratios suggested that dysregulations of enzymes such as D6 desaturase, D5 desaturase, and elongases for polyunsaturated fatty acids in patients with multi-episode schizophrenia could account for the differences. Additionally, certain fatty acid level/ratio changes were positively correlated with symptom improvement. The alterations of C22:5n3 and omega-3 index, gender, and the number of episodes were significant risk factors correlated with treatment responsiveness. Using targeted metabolomic approach, we revealed the potential mechanisms underlying abnormal fatty acid metabolism responsible for reduced treatment response in patients with multi-episode schizophrenia.https://doi.org/10.1038/s41537-022-00214-2
spellingShingle Nana Li
Ping Yang
Mimi Tang
Yong Liu
Wenbin Guo
Bing Lang
Jianjian Wang
Haishan Wu
Hui Tang
Yan Yu
Xiangxin Wu
Cuirong Zeng
Ting Cao
Hualin Cai
Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
npj Schizophrenia
title Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
title_full Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
title_fullStr Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
title_full_unstemmed Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
title_short Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
title_sort reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi versus first episode schizophrenia
url https://doi.org/10.1038/s41537-022-00214-2
work_keys_str_mv AT nanali reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT pingyang reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT mimitang reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT yongliu reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT wenbinguo reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT binglang reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT jianjianwang reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT haishanwu reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT huitang reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT yanyu reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT xiangxinwu reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT cuirongzeng reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT tingcao reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia
AT hualincai reducederythrocytemembranepolyunsaturatedfattyacidlevelsindicatediminishedtreatmentresponseinpatientswithmultiversusfirstepisodeschizophrenia